Atlas Trials

Yang Hong

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yang Hong

RecordFirmDate
Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC (NCT07309952)Yang Hong2025-12-31
Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study (NCT06598527)Yang Hong2024-10-15

Track Yang Hong automatically

Every clearance here is in the API, with alerts when new ones post.